Methylphenidate (Neutif, Satefin, Metheylphenidate Sun)
Methylphenidate
Ranbaxy Pharmaceutical (Pty) Ltd
Every registration of this product has been cancelled.
Registration
- Applicant
- Ranbaxy Pharmaceutical (Pty) Ltd
- Registrations
- 11
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Neutif 27 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 27,0 mg | 27 | 55081755/1.2/0817 | Cancelled | S6 | None |
| Neutif 36 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 36,0 mg | 36 | 55081855/1.2/0818 | Cancelled | S6 | None |
| Neutif 54 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 54,0 mg | 54 | 55081955/1.2/0819 | Cancelled | S6 | None |
| Satefin 18 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 18,0 mg | 18 | 550820.81655/1.2/0820.816 | Cancelled | S6 | None |
| Satefin 27 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 27,0 mg | 27 | 550821.81755/1.2/0821.817 | Cancelled | S6 | None |
| Satefin 36 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 36,0 mg | 36 | 550822.81855/1.2/0822.818 | Cancelled | S6 | None |
| Satefin 54 EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 54,0 mg | 54 | 550823.81955/1.2/0823.819 | Cancelled | S6 | None |
| Metheylphenidate 18 sun EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 18,0 mg | 18 | 550824.81655/1.2/0824.816 | Cancelled | S6 | None |
| Metheylphenidate 27 sun EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 27,0 mg | 27 | 550825.81755/1.2/0825.817 | Cancelled | S6 | None |
| Metheylphenidate 36 sun EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 36,0 mg | 36 | 550826.81855/1.2/0826.818 | Cancelled | S6 | None |
| Metheylphenidate 54 sun EACH TABLET CONTAINS METHYLPHENIDATE HYDROCHLORIDE 54,0 mg | 54 | 550827.81955/1.2/0827.819 | Cancelled | S6 | None |
Regulatory status
Where S6 sits on the scale
Prescription-only, no repeats without a new prescription.
Schedule 6 covers the most tightly controlled ordinary prescription medicines. Every dispensing needs its own new prescription; nothing can be repeated on the same script. When prescribed, the quantity must be written out in both figures and words. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S6, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Methylphenidate hydrochloride
S6: Methylphenidate
- and its derivatives, unless listed in another Schedule.
Consolidated Schedules 06 July 2026, line 10310
Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Methyl 2-phenyl-2-piperidin-2-ylacetate
Drag to rotate. Structure from PubChem CID 4158.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.